Point72 Asset Management’s Cellectis CLLS Stock Holding History

Point72 Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,314	Closed	-$132K	–	3858
2025 Q4	$132K	Buy	+27,314	New	+$114K	﹤0.01%	3707
2020 Q1	–	Sell	-42,688	Closed	-$731K	–	811
2019 Q4	$731K	Sell	42,688 -146,312	-77%	-$1.95M	﹤0.01%	751
2019 Q3	$1.97M	Buy	189,000 +46,500	+33%	+$625K	0.01%	595
2019 Q2	$2.22M	Buy	142,500 +57,100	+67%	+$1.02M	0.01%	638
2019 Q1	$1.57M	Sell	85,400 -314,600	-79%	-$5.58M	0.01%	742
2018 Q4	$6.66M	Buy	400,000 +243,867	+156%	+$5.65M	0.03%	488
2018 Q3	$4.41M	Buy	156,133 +84,533	+118%	+$2.43M	0.02%	628
2018 Q2	$2.03M	Buy	71,600 +1,600	+2%	+$47.6K	0.01%	753
2018 Q1	$2.21M	Buy	+70,000	New	+$2.21M	0.01%	720
2015 Q4	–	Sell	-35,000	Closed	-$923K	–	697
2015 Q3	$923K	Buy	+35,000	New	+$1.17M	0.01%	625
2015 Q2	–	Sell	-65,000	Closed	-$2.25M	–	733
2015 Q1	$2.25M	Buy	+65,000	New	+$2.36M	0.02%	548

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Point72 Asset Management's CLLS Position: Q1 2026 in Review

Point72 Asset Management sold out of Cellectis (CLLS) in Q1 2026, closing a stake of 27,314 shares — an estimated $132K sold.

Point72 Asset Management first reported a position in CLLS in Q1 2015 and held it in 11 quarters. The position peaked at $6.66M in Q4 2018. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

Point72 Asset Management reported no remaining Cellectis position as of Q1 2026 after selling out during the quarter.
Point72 Asset Management sold 27,314 Cellectis shares in Q1 2026, an estimated $132K.
Point72 Asset Management first reported a position in Cellectis in Q1 2015 and held it in 11 quarters.
Point72 Asset Management's Cellectis position peaked at $6.66M in Q4 2018.
32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.